by Brook White | May 13, 2021 | Blog, Press Releases
This week, the Journal of Clinical Neurophysiology published a special issue about recent innovations and their regulatory implications for clinical trials in multiple sclerosis. Dr. Mark Skeen, Senior Medical Scientist at VeraSci and Professor of Neurology at Duke... by Brook White | May 10, 2021 | Press Releases, Uncategorized
The 20Sense Report, a quarterly publication for Canada’s specialty pharmaceutical industry, featured VeraSci’s Dr. Luca Pani in their April 2021 issue discussing creative approaches to market access. The article compares the agreements that have been used in Italy to... by Brook White | May 6, 2021 | Blog
Members of the Parkinson’s Foundation and the Parkinson’s Study Group (PSG), including VeraSci Senior Clinical Director of Movement Disorders Dr. Travis Turner, recently published a consensus statement titled “Expediting telehealth use in clinical research studies:... by Brook White | Apr 30, 2021 | Posters
Presented at the International Society for CNS Clinical Trials and Methodology (ISCTM) Annual Scientific Meeting Virtual Edition, April 6-9, 2021 While episodic memory impairment is often the hallmark of mild cognitive impairment (MCI) due to Alzheimer’s disease... by Brook White | Apr 26, 2021 | Posters
Presented at the American Academy of Neurology Virtual Annual Meeting, April 17-22, 2021 The VRFCAT-SL was administered to a sample of 29 patients with Parkinson’s disease during clinical neuropsychological evaluation. Based on the analysis presented in this...